Cryo-Cell International
CCEL
20 hedge funds and large institutions have $5.17M invested in Cryo-Cell International in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.43% less ownership
Funds ownership: 12.76% → 12.33% (-0.43%)
5% less funds holding
Funds holding: 21 → 20 (-1)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
21% less capital invested
Capital invested by funds: $6.57M → $5.17M (-$1.39M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22.1K |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
+$4.75K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.17K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
-$197K |
| 2 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
-$64.4K |
| 3 |
TCM
Topline Capital Management
Santa Monica,
California
|
-$38.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.36K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.98K |
CCEL Hedge Fund Activity: Q2 2025 in Review
20 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q2 2025, worth a combined $5.17M — down 21% from $6.57M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CCEL and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $61.1K. The largest seller was Heron Bay Capital Management, exiting entirely with an estimated $197K sold.
- 20 institutional investors held Cryo-Cell International (CCEL) as of Q2 2025, down from 21 in Q1 2025.
- Funds reported $5.17M of Cryo-Cell International stock for Q2 2025, down 21% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest Cryo-Cell International buyer in Q2 2025 was Vanguard Group, an estimated $61.1K added.
- The largest Cryo-Cell International seller in Q2 2025 was Heron Bay Capital Management, an estimated $197K sold.
Based on aggregated 13F filings for Q2 2025.